DEERFIELD MANAGEMENT COMPANY, L.P.

Position in TNGX — Tango Therapeutics, Inc.

CIK 1009258 NEW YORK, NY

Position in TNGX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$86,751,327

+$60,995,786 QoQ

Shares Held

4,146,813

+42.7% QoQ

Ownership

2.87%

of shares outstanding

% of Portfolio

1.21%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

DEERFIELD MANAGEMENT COMPANY, L.P. holds $5,090,522,306 across 44 Biotechnology names. TNGX ranks #16 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NUVL	Nuvalent, Inc.	17,248,450	$1,767,103,702
2	COGT	Cogent Biosciences, Inc.	9,043,903	$348,099,826
3	PRAX	Praxis Precision Medicines, Inc.	963,351	$310,382,058
4	RVMD	Revolution Medicines, Inc.	2,297,000	$223,383,250
5	CELC	Celcuity Inc.	1,714,000	$195,635,960
6	LRMR	Larimar Therapeutics, Inc.	35,606,974	$160,231,383
7	VERA	Vera Therapeutics, Inc.	3,722,100	$149,740,083
8	IONS	Ionis Pharmaceuticals Inc	1,979,669	$148,653,345

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$86,751,327	4,146,813	+42.7%	Shares	Defined	2026-05-15
2025-12-31	$25,755,541	2,906,946	+88.8%	Shares	Defined	2026-02-17
2024-09-30	$11,858,000	1,540,000	0.0%	Shares	Defined	2024-11-14
2024-06-30	$13,213,200	1,540,000	0.0%	Shares	Defined	2024-08-14
2024-03-31	$12,227,600	1,540,000	0.0%	Shares	Defined	2024-05-15
2023-12-31	$15,246,000	1,540,000	+94.0%	Shares	Defined	2024-02-14
2023-09-30	$8,937,388	793,729	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.